INDIANAPOLIS, Dec. 11, 2017 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received a Military Friendly® Employers Gold Award by Victory Media in the Over $1B revenue category. First published in 2003, Military Friendly® Employers is the most comprehensive, powerful resource for veterans today. Each year, the list of Military Friendly® Employers is provided to service members and their families, helping them discover the best post-military career opportunities available.
Roche Diagnostics is committed to hiring military talent, knowing first-hand that recruiting veterans and military spouses is not only the "right thing to do," but the right thing for business. "We've had great success bringing veterans into our organization because people with military backgrounds are inherently good at connecting with a mission and are used to working through challenges and hardships," says Jay Graves, Vice President of Diabetes Care Sales and executive sponsor of the Indianapolis veterans business resource group. "On campus, our veterans business resource group brings together the community of veterans and promotes the understanding of the service culture within our company through communications and events that raise awareness."
Roche will be showcased along with other 2018 Military Friendly® Employers in the December issue of G.I. Jobs® magazine, the January 2018 issue of Military Spouse magazine and on MilitaryFriendly.com.
"Companies that have earned this designation have exceptionally strong hiring programs and meaningful jobs for transitioning service members, veterans and spouses," said Daniel Nichols, Chief Product Officer at Victory Media. "Our Military Friendly® Employers have moved beyond answering 'why hire military?' They are truly aligning their jobs and recruiting efforts with Military Friendly® Schools to translate military competencies into civilian careers."
Companies and organizations earning the Military Friendly® Employer designation were evaluated using both public data sources and responses from a proprietary survey. For the first time, veteran employee satisfaction surveys were collected and intended to be implemented into ratings next cycle. More than 200 companies participated in the Military Friendly® Employers portion of the 2018 Military Friendly® Companies survey.
The methodology, criteria, and weightings were determined by Victory Media with input from the Military Friendly Advisory Council of independent leaders in the higher education and military recruitment community. Final ratings were determined by combining an organization's survey score with an assessment of the organization's ability to meet thresholds for Applicant, New Hire Retention, Employee Turnover, and Promotion & Advancement of veterans and military employees.
About Military Friendly® Employers:
The Military Friendly® Employers list is created each year based on extensive research using public data sources, input of military employees, and responses to the proprietary, data-driven Military Friendly® Employers survey from participating companies. The survey questions, methodology, criteria and weightings were developed with the assistance of an independent research firm and an advisory council of educators and employers. Data calculations and tabulations were independently evaluated for completeness and accuracy by Ernst & Young. The survey is administered for free and is open to companies that have hired veterans in the past 12 months. Criteria for consideration can be found at: www.militaryfriendly.com
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com or usdiagnostics.roche.com.
All trademarks used or mentioned in this release are protected by law.
About Victory Media:
Founded in 2001, Victory Media is a service-disabled, veteran-owned small business (SDVOSB) that connects the military community to civilian employment, educational and entrepreneurial opportunities through its G.I. Jobs® and Military Friendly® brands. Victory Media and its brands are not a part of or endorsed by the U.S. Dept. of Defense or any federal government entity. Learn more about Victory Media at www.victorymedia.com.
For further information, please contact:
Communications Business Partner
Roche Diagnostics Corporation
Gordon C. James PR
View original content with multimedia:http://www.prnewswire.com/news-releases/roche-diagnostics-named-a-military-friendly-employer-by-victory-media-300569255.html
SOURCE Roche Diagnostics